文献速递妇科

医院手术量对早期宫颈癌根治性子宫切除术后生存的影响

Association of Hospital Surgical Volume With Survival in Early-Stage Cervical Cancer Treated With Radical Hysterectomy.
PubMed 文献 · Obstet Gynecol · 2022-11-30

这项国际多中心回顾性研究纳入2157例FIGO 2009分期IB1-IIA1期、根治性子宫切除术后淋巴结阴性的宫颈癌患者,以7例和17例手术量为界分为低、中、高容量中心。倾向性评分匹配后分析1238例,高容量中心5年无病生存率优于中、低容量中心(92.3% vs 88.9% vs 83.8%,P=.029),5年总生存率无差异(95.9% vs 97.2% vs 95.2%,P=.70)。

要点

  • 高容量中心5年无病生存率92.3%,优于中容量88.9%和低容量83.8%(P=.029)。
  • 三组5年总生存率分别为95.9%、97.2%、95.2%,无统计学差异(P=.70)。
  • 低容量中心是复发的独立危险因素,年根治性子宫切除手术量增加与无病生存改善相关。

核心结论

  • 中心手术量是影响无病生存的独立预后因素,每年根治性子宫切除数量增加与无病生存改善相关。

研究设计与样本

  • 国际多中心回顾性研究,纳入宫颈癌监测协作研究中FIGO 2009分期IB1-IIA1期、根治性子宫切除术后最终组织学淋巴结阴性的患者,初始纳入2157例,倾向性评分匹配后分析1238例。

主要发现

  • 以7例和17例手术量为界分为低、中、高容量中心;匹配后高容量组619例(50.0%)、中容量组523例(42.2%)、低容量组96例(7.8%)。
  • 高容量中心5年无病生存率92.3%,中容量中心88.9%,低容量中心83.8%(P=.029)。
  • 高容量中心5年总生存率95.9%,中容量中心97.2%,低容量中心95.2%(P=.70),无差异。
  • Cox多因素回归显示FIGO分期大于IB1、脉管间隙浸润、分级大于1、肿瘤直径大于20 mm、微创手术方式、非鳞状细胞癌组织学及低容量中心为复发的独立危险因素。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: To evaluate the association of number of radical hysterectomies performed per year in each center with disease-free survival and overall survival. METHODS: We conducted an international, multicenter, retrospective study of patients previously included in the Surveillance in Cervical Cancer collaborative studies. Individuals with International Federation of Gynecology and Obstetrics (FIGO) 2009 stage IB1-IIA1 cervical cancer who underwent radical hysterectomy and had negative lymph nodes at final histology were included. Patients were treated at referral centers for gynecologic oncology according to updated national and international guidelines. Optimal cutoffs for surgical volume were identified using an unadjusted Cox proportional hazard model, with disease-free survival as the outcome and defined as the value that minimizes the P-value of the split in groups in terms of disease-free survival. Propensity score matching was used to create statistically similar cohorts at baseline. RESULTS: A total of 2,157 patients were initially included. The two most significant cutoffs for surgical volume were identified at seven and 17 surgical procedures, dividing the entire cohort into low-volume, middle-volume, and high-volume centers. After propensity score matching, 1,238 patients were analyzed-619 (50.0%) in the high-volume group, 523 (42.2%) in the middle-volume group, and 96 (7.8%) in the low-volume group. Patients who underwent surgery in higher-volume institutions had progressively better 5-year disease-free survival than those who underwent surgery in lower-volume centers (92.3% vs 88.9% vs 83.8%, P=.029). No difference was noted in 5-year overall survival (95.9% vs 97.2% vs 95.2%, P=.70). Cox multivariable regression analysis showed that FIGO stage greater than IB1, presence of lymphovascular space invasion, grade greater than 1, tumor diameter greater than 20 mm, minimally invasive surgical approach, nonsquamous cell carcinoma histology, and lower-volume centers represented independent risk factors for recurrence. CONCLUSION: Surgical volume of centers represented an independent prognostic factor affecting disease-free survival. Increasing number of radical hysterectomies performed in each center every year was associated with improved disease-free survival.

来源:Obstet Gynecol,查看原文。版权归原作者所有。

引用

  1. Bizzarri N, Dostálek L, van Lonkhuijzen LRCW, et al. Association of Hospital Surgical Volume With Survival in Early-Stage Cervical Cancer Treated With Radical Hysterectomy. Obstet Gynecol. 2022. PMID: 36701621. doi:10.1097/AOG.0000000000005026

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。